8 Bridge Group Acquires Majority Stake in 340BIntel

Citybiz reports that 8 Bridge Group has acquired a majority stake in 340BIntel, a healthcare technology company. According to Citybiz, the transaction expands 8 Bridge Group’s healthcare technology portfolio.

Majority-stake transaction announced

The Citybiz report identifies 8 Bridge Group as the acquirer of a majority stake in 340BIntel. The announcement centers on an ownership transaction involving a company operating in healthcare technology.

Citybiz describes 340BIntel as a company specializing in software that helps hospitals. The published summary characterizes the acquisition as an expansion of 8 Bridge Group’s healthcare technology portfolio.

No transaction terms, financial details, leadership changes, product plans, or commercial-operating updates are included in the supplied Citybiz evidence. The available report establishes the majority-stake acquisition and identifies 340BIntel’s hospital-focused software specialization.

Hospital software remains the focus

For medical sales professionals whose customers include hospitals and health systems, the announcement is a relevant ownership event in the healthcare technology sector. The evidence supplied by Citybiz places 340BIntel’s work in software designed to help hospitals.

The deal also connects 8 Bridge Group’s portfolio expansion with a healthcare technology organization serving hospital users. Sales professionals tracking technology vendors, hospital-facing software, and changes in company ownership can note the transaction as reported by Citybiz.

For veterinary sales professionals, the announcement is a broader healthcare technology transaction rather than a veterinary-specific development. Citybiz’s summary does not describe veterinary applications, customers, products, or operations.

What the report confirms

• 8 Bridge Group acquired a majority stake in 340BIntel, according to Citybiz.
• 340BIntel specializes in software that helps hospitals, according to Citybiz.
• The acquisition expands 8 Bridge Group’s healthcare technology portfolio, according to Citybiz.

Further details about the companies’ plans are not provided in the supplied evidence.